Replies to post #199505 on Cytodyn Inc (CYDY)

[JPG77]

They're still working on the 700mg topline report. Why would there be any mention of the results when they're still compiling them???

The proactive video makes no mention of the 700 mg part of the Nash trials. If there was anything good about the results there, I expect Nader to have highlighted that as something to look forward to.

Why would anyone assume the trial failed with 700mg when it's twice the dosage of the 350mg trial that met the primary endpoints???

I wonder if LL can really be regarded as effective on Nash with 350 mg if it fails with 700.

Why should management explain the 700mg side prior to completing the topline report??? The 700mg topline report is expected to confrim that LL will easily become the new SOC for NASH given the fantastic results from the 350mg trial, and nothing less! There is no current SOC that comes close to matching LL's efficacy on NASH and with NO SAE's. BPs will be salivating after they release the topline results. Be prepared for potential partnering news within the next couple of months.

Management should explain the 700 side, what happened.